Genetic hemochromatosis is an autosomal recessive disease characterize
d by increased intestinal iron absorption and consequent tissue iron o
verload. The hemochromatosis gene has been localized on the short arm
of chromosome 6, in close proximity to the HLA locus, but has yet to b
e identified. Neither the gene product nor the pathogenetic defect hav
e been characterized. Clinical manifestations vary according to the de
gree of iron overload, ranging from the asymptomatic state to the feat
ures of cirrhosis and hepatocellular carcinoma. Early diagnosis remain
s essential, since the survival of patients without established cirrho
sis is comparable to that of the general population. Transferrin satur
ation and ferritin levels are suggestive of the diagnosis, but measure
ment of the hepatic iron concentration still remains the gold standard
, despite the utilization of computerized tomography and magnetic reso
nance imaging. Routine phlebotomies constitute the principal therapeut
ic option, despite the recent preliminary data on oral iron chelators.